Clinical Trial Update: Sitagliptin in Recurrent/Progressive Grade 4 Glioma [Phase 1]

View source ↗

Summary

Clinical trial update describing a Phase 1 study of sitagliptin in recurrent or progressive glioma and glioblastoma, with status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Kailin Yang, MD, PhD | Conditions: Glioma, Glioblastoma | Phase 1 | Status: NOT_YET_RECRUITING